Related Experiment Video
Updated: Nov 25, 2025

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Results of reconstructive interventions in patients with ischemic cardiomyopathy
Vladimir M Shipulin1, Andrey S Pryakhin1, Sergey L Andreev1
1Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.
Insights
Left ventricular reconstruction combined with coronary artery bypass grafting significantly improves chronic heart failure outcomes in ischemic cardiomyopathy patients. This surgical approach enhances functional capacity and reduces heart failure markers long-term.
Area of Science:
- Cardiovascular Surgery
- Cardiology
- Heart Failure Management
Background:
- Ischemic cardiomyopathy presents significant challenges in cardiac surgery.
- Effective long-term treatment strategies for patients with chronic heart failure due to ischemic cardiomyopathy are crucial.
Purpose of the Study:
- To evaluate the long-term effectiveness of left ventricular reconstructive interventions in patients with ischemic cardiomyopathy and chronic heart failure.
- To compare outcomes of isolated coronary artery bypass grafting (CABG) versus CABG combined with left ventricular reconstruction.
Main Methods:
- A study involving 178 patients with ischemic cardiomyopathy between March 2013 and December 2017.
- Propensity score matching analysis to compare isolated CABG with CABG plus left ventricular reconstruction.
- Primary endpoints included hospital mortality and long-term survival.
Main Results:
- Propensity score matching resulted in 29 comparable pairs of patients.
- 30-day hospital mortality and long-term all-cause mortality were similar between groups (6.8% vs 6.8%, p=0.952 and p=0.352, respectively).
- Patients undergoing CABG with left ventricular reconstruction showed significant improvements in peak oxygen consumption (p=0.043) and reduced N-terminal pro-brain natriuretic peptide levels (p=0.032) compared to isolated CABG.
Conclusions:
- Coronary artery bypass grafting combined with left ventricular reconstruction offers significant long-term benefits for patients with ischemic cardiomyopathy.
- This combined surgical approach leads to a notable decrease in clinical and functional parameters of chronic heart failure postoperatively.
- Left ventricular reconstruction is a valuable adjunct to CABG for improving heart failure indicators in this patient population.
Background:
Effective treatment of patients with ischemic cardiomyopathy is one of the most difficult issues in contemporary cardiac surgery. The aim of this study was to evaluate the long-term effectiveness of reconstructive interventions on the left ventricle during chronic heart failure in patients with ischemic cardiomyopathy.
Methods:
Between March 2013 and December 2017, 178 patients underwent surgical treatment for ischemic cardiomyopathy. Isolated coronary artery bypass grafting was compared with coronary artery bypass grafting with left ventricular reconstruction, using propensity score matching analysis. The primary endpoints of the study were hospital mortality and long-term survival.
Results:
After propensity score matching, 29 pairs of patients were compared. The 30-day hospital mortality was comparable (6.8% versus 6.8%, p = 0.952), the average follow-up was 37.4 ± 12.6 months, with no statistically significant difference in mortality from all causes (p = 0.352). After coronary artery bypass in combination with left ventricular reconstruction, patients showed a statistically significant decrease in clinical and functional indicators of chronic heart failure compared to those who had coronary artery bypass grafting alone, in terms of peak oxygen consumption (15.3 versus 13.5 mL·kg-1·min-1, p = 0.043) and N-terminal pro-brain natriuretic peptide concentrations (298.6 versus 461.1 pg·mL-1, p = 0.032).
Conclusions:
Compared to isolated coronary artery bypass, coronary artery bypass in combination with left ventricular reconstruction for the treatment of ischemic cardiomyopathy leads to a significant decrease in the clinical and functional parameters of chronic heart failure in the long-term postoperative period.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy VI: Nursing Management

